Shanghai Alebund Pharmaceuticals Limited
1 clinical trials · Sponsor
◉ Watch Shanghai Alebund Pharmaceuticals Limited
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Study to Evaluate the Safety and Efficacy of VS-505(AP301) to Treat Hyperphosphatemia in Hemodialysis Patients (NCT04551300) | Shanghai Alebund Pharmaceuticals Limited | 2020-10-13 |
Track Shanghai Alebund Pharmaceuticals Limited automatically
Every clearance here is in the API, with alerts when new ones post.